Bahrain - English - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

gulf pharmacy - cilastatin sodium, imipenem - powder for soln. for injection - 500

India - English - Central Drugs Standard Control Organization

ranbaxy - vial

Bahrain - English - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

gulf pharmacy - cilastatin sodium, imipenem - powder for soln.for infusion - 500

Bangladesh - English - DGDA (Directorate General of Drug Administration)

eskayef pharmaceuticals ltd., narayanganj - cilastatin + imipenem - iv/im injection - 500 mg + 500 mg

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع ادوية رضا جردانة - reda jardaneh drug store - cilastatin 500 mg/vial, imipenem anhydrous 500 mg/vial - 500 mg/vial, 500 mg/vial

United States - English - NLM (National Library of Medicine)

eisai inc. - lecanemab (unii: 12pyh0ftu9) (lecanemab - unii:12pyh0ftu9) - leqembi is indicated for the treatment of alzheimer’s disease. treatment with leqembi should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the population in which treatment was initiated in clinical trials. leqembi is contraindicated in patients with serious hypersensitivity to lecanemab-irmb or to any of the excipients of leqembi. reactions have included angioedema and anaphylaxis [see warnings and precautions (5.2) ] . risk summary there are no adequate data on leqembi use in pregnant women to evaluate for a drug associated risk of major birth defects, miscarriage, or other adverse maternal or fetal outcomes. no animal studies have been conducted to assess the potential reproductive or developmental toxicity of leqembi.  in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively. the background risk of major birth defects and miscarriage for th

Kenya - English - Pharmacy and Poisons Board

cachet pharmaceuticals pvt. ltd 415, shah nahar, worli, mumbai-400018 - meropenum trihydrate usp - injection - meropenum trihydrate usp 1000mg - beta-lactamantibacterials: carbapenems

Kenya - English - Pharmacy and Poisons Board

cachet pharmaceuticals pvt. ltd 415, shah nahar, worli, mumbai-400018 - meropenum trihydrate usp - injection - meropenum trihydrate usp 500mg - beta-lactamantibacterials: carbapenems

Philippines - English - FDA (Food And Drug Administration)

cachet pharmaceuticals pvt. ltd.; importer: genpharm, inc.; distributor: britton distributions, inc. - meropenem(as trihydrate) - powder for injection (iv) - 1g

Ireland - English - HPRA (Health Products Regulatory Authority)

netpharmalab consulting services s. l. - cefotaxime - powder for solution for injection/infusion - 1 gram(s) - third-generation cephalosporins; cefotaxime